PICOCYL Company Profile

Background

PICOCYL is a privately held company specializing in the design, development, and manufacturing of innovative gas-powered solutions for the medical and pharmaceutical industries. Founded in 2016 and headquartered in Golden, Colorado, PICOCYL has established itself as a pioneer in creating unique energy sources for drug delivery systems. The company's flagship product, the Pico-Cylinder, has become the industry standard for single-use, gas-powered devices, enabling more ergonomic and effective drug delivery applications.

Key Strategic Focus

PICOCYL's strategic focus centers on advancing drug delivery technologies through its proprietary gas-powered solutions. The company specializes in developing Pico-Cylinders, which are small, medical-grade, pressurized gas cylinders designed to power various drug delivery devices, including autoinjectors, wearable injectors, and implantable systems. By leveraging these technologies, PICOCYL aims to enhance patient outcomes by providing reliable and efficient drug delivery mechanisms.

Financials and Funding

As of the latest available data, PICOCYL generates approximately $4.5 million in annual revenue and employs around 43 individuals across all locations. The company has raised a total of $150,000 in funding over one round.

Pipeline Development

PICOCYL's product line includes various sizes of Pico-Cylinders tailored for specific applications:

160 µL Breakaway Septum Pico-Cylinder: Targeted for novel ingestible drug delivery systems, enhancing bioavailability by delivering drugs directly to the gastrointestinal tract.

1 mL Breakaway Septum Pico-Cylinder: Designed for wearable applications and life-critical autoinjectors.

700 µL Breakaway Septum Pico-Cylinder: The company's first mass-produced Pico-Cylinder, used in commercial medical device implants and drug delivery systems, with over 5 million units shipped worldwide.

Technological Platform and Innovation

PICOCYL's innovation is anchored in its proprietary Pico-Cylinder technology, which offers several advantages:

Proprietary Technologies: The Pico-Cylinder features a patented low-force breakaway septum cap and precision-matched Opener Pin, delivering the right amount of stored energy with minimal opening force.

Significant Scientific Methods: The design allows for precise control over drug delivery, accommodating high-viscosity formulations and large dose volumes, which are challenging for traditional spring-powered systems.

Leadership Team

Bob Barron: Chief Executive Officer

Chris Dorsey: Vice President of Operations

Kassandra Smith: Operations Manager

In September 2023, Kassandra Smith was promoted to Operations Manager, assuming responsibilities for day-to-day management and oversight of all manufacturing facilities and operations.

Competitor Profile

Market Insights and Dynamics

The global micro gas cylinder market was valued at approximately $933.4 million in 2024 and is projected to reach $1,752.1 million by 2034, growing at a CAGR of 6.5%. This growth is driven by increasing demand for compact gas storage systems in healthcare, automotive, and electronics industries.

Competitor Analysis

Key competitors in the micro gas cylinder market include:

ISI Components

Gas Cylinder Technology

NTG

Leland

These companies offer similar gas-powered solutions and compete with PICOCYL in various applications, including medical devices and industrial uses.

Strategic Collaborations and Partnerships

PICOCYL collaborates with medical device designers and pharmaceutical companies to integrate its Pico-Cylinder technology into innovative drug delivery systems. These partnerships aim to address the challenges of delivering high-viscosity biologics and large-dose volumes, enhancing patient care and expanding the company's market reach.

Operational Insights

In response to surging demand, PICOCYL expanded its U.S.-based manufacturing facility by over 60% in 2023. The expansion included the addition of a state-of-the-art, fully automated production line capable of manufacturing multiple products with unique variations. The facility features an ISO 13485:2016 certified quality system and a Class 8 cleanroom, ensuring high-quality production standards.

Strategic Opportunities and Future Directions

PICOCYL is well-positioned to capitalize on the growing demand for advanced drug delivery systems, particularly for high-viscosity biologics and large-dose formulations. By continuing to innovate and expand its product offerings, the company aims to strengthen its market position and contribute to the development of next-generation therapies.